News & Articles

New kit is designed to enable short term prediction of pre-eclampsia and aid in diagnosis in the second and third trimesters of pregnancy

Discover how you can boost your research with screen-printed and interdigitated electrodes

To be in with a chance of winning a $500 Amazon Gift Card, simply cast your vote for the product that has made the most difference to your work

Our expert webinar series aims to help you get the most from your drug discovery research

The trial will study the use of ruxolitinib, a JAK inhibitor, to investigate its effect on reducing complications in deteriorating COVID-19 patients

A rare lung disease drug is being trialed to help fight COVID-19

The study is expected to begin enrolling in June with a target of approximately 450 patients globally

People who recovered from COVID-19 shows that most individuals had generated antibodies that were intrinsically capable of neutralizing the SARS-CoV-2 virus

Microsemi CRP hematology analyzers have been installed during COVID-19 ‘lockdown’ in POC locations to help reduce hospital admissions

The cPass™ – SARS-CoV-2 Surrogate Virus Neutralization Test (sVNT) Kit aims to detect the presence of neutralizing antibodies in an hour

Interim clinical study data shows ID NOW test performance of 94.7% sensitivity and 98.6% specificity

Driven by the gap in COVID-19 testing, the collaboration aims to create a fully disposable, rapid and handheld test for consumers

A qualitative test for the detection of nucleic acid from SARS-CoV-2

Study suggests that type I IFN deficiency in the blood could help define a high-risk population

The COVID-19 vaccine trial is part of a global development program that will uncover the safety and immunogenicity of four mRNA vaccine candidates.

Test deployed on Quanterix' Simoa platform promises 1,000-fold sensitivity improvement

The company says it continues to optimize its coronavirus test amid questions about its accuracy

The digital tool could help simplify the screening, diagnosis and monitoring of patients with respiratory compromise in the current COVID-19 pandemic

A portable and non-invasive, fingerprint-based method, ideal for on-site testing in care homes and the workplace

Leading HPLC analyzer manufacturer Tosoh Europe partners with EKF for Quo-Test HbA1c point-of-care analyzer

Mass production comes as part of a nationwide effort to support the NHS in the fight against COVID-19